New pill for eczema shows promise in early trial
NCT ID NCT06945458
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 28 times
Summary
This early-stage study tested an oral medication called KT-621 in 22 adults with moderate to severe atopic dermatitis (eczema). The main goal was to check safety and how the body processes the drug. Researchers also looked for signs that the drug might help control the condition, but this was a small, short-term trial focused on safety first.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Kymera Investigative Site
Birmingham, Alabama, 35244, United States
-
Kymera Investigative Site
Fountain Valley, California, 92708, United States
-
Kymera Investigative Site
Santa Monica, California, 90404, United States
-
Kymera Investigative Site
Boynton Beach, Florida, 33436, United States
-
Kymera Investigative Site
Hollywood, Florida, 33024, United States
-
Kymera Investigative Site
Tampa, Florida, 33613, United States
-
Kymera Investigative Site
Fargo, North Dakota, 58078, United States
-
Kymera Investigative Site
Dublin, Ohio, 43016, United States
-
Kymera Investigative Site
Springfield, Ohio, 45505, United States
-
Kymera Investigative Site
Tulsa, Oklahoma, 74136, United States
-
Kymera Investigative Site
Charleston, South Carolina, 29420, United States
-
Kymera Investigative Site
San Antonio, Texas, 78213, United States
Conditions
Explore the condition pages connected to this study.